Sarepta Therapeutics (SRPT) Accumulated Expenses (2013 - 2026)
Sarepta Therapeutics' Accumulated Expenses was $325.23 million in Q2 2026, down 13.8% from $377.4 million a year earlier but up 7.6% from the prior quarter.
Sarepta Therapeutics (SRPT) Accumulated Expenses (2013 - 2026) Analysis & Trends
At the end of FY2025, Accumulated Expenses at Sarepta Therapeutics came in at $359.66 million, down 3.7% from FY2024.
- Accumulated Expenses shows a five-year compound annual growth rate of 13.2% (FY2020 to FY2025).
- In earlier years, Accumulated Expenses was $373.51 million in FY2024 (+18.6%), $315 million in FY2023 (-24.8%), $419 million in FY2022 (+54.2%) and $271.7 million in FY2021 (+40.4%).
- Quarterly Accumulated Expenses has moved between $221.01 million (Q3 2021) and $419 million (Q4 2022) over five years.
- Compared with a year earlier, Accumulated Expenses has declined for four straight quarters, with growth averaging 2.1% over the last eight quarters.
- The best year-over-year quarter for Accumulated Expenses over five years was Q3 2022 (growth of 67.0%); the worst was Q4 2023 (a decline of 24.8%).
- Per Business Quant data, SRPT's Accumulated Expenses in the three quarters before Q2 2026 was $302.37 million (Q1 2026), $359.66 million (Q4 2025) and $295.79 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Sarepta Therapeutics | 1.92 Bn | -1.31 Bn | 251.87 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 325.23 Mn |
| Mar 31, 2026 | 302.37 Mn |
| Dec 31, 2025 | 359.66 Mn |
| Sep 30, 2025 | 295.79 Mn |
| Jun 30, 2025 | 377.40 Mn |
| Mar 31, 2025 | 391.65 Mn |
| Dec 31, 2024 | 373.51 Mn |
| Sep 30, 2024 | 344.83 Mn |
| Jun 30, 2024 | 350.40 Mn |
| Mar 31, 2024 | 283.32 Mn |
| Dec 31, 2023 | 315.00 Mn |
| Sep 30, 2023 | 322.35 Mn |
| Jun 30, 2023 | 326.88 Mn |
| Mar 31, 2023 | 345.55 Mn |
| Dec 31, 2022 | 419.00 Mn |
| Sep 30, 2022 | 369.00 Mn |
| Jun 30, 2022 | 383.70 Mn |
| Mar 31, 2022 | 293.91 Mn |
| Dec 31, 2021 | 271.70 Mn |
| Sep 30, 2021 | 221.01 Mn |
Sarepta Therapeutics Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=SRPT&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accumulated-expenses", "ticker": "SRPT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=SRPT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();